BCR and diffuse large B-cell lymphoma: The oncogenetic molecular mechanisms involved in ABC-DLBCL were primarily initiated by BCR subunit activated mutations, as well as the CARD11 and MYD88 mutations, resulting in the constitutive activation of NF-κB [16, 24].